Skip to content

Author

Nermin Keni Begendi

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Enhanced Antileukemic Efficacy of Venetoclax-Loaded PEG-PLGA Nanoparticles Against THP-1 Acute Monocytic Leukemia Cells via Suppression of BCL-2 and Pro-Survival Signaling Pathways

Background: Acute myeloid leukemia (AML) presents a significant therapeutic challenge due to the systemic toxicity associated with traditional chemotherapy. Venetoclax, a selective BCL-2 inhibitor, has shown promising antileukemic activity; however, limited pharmacokinetic properties impair its clinical use. Polymeric...

Nermin Keni Begendi, E. Kaga · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.